Phathom Pharmaceuticals to present VOQUEZNA clinical data at DDW2026 event

Phathom Pharmaceuticals to present VOQUEZNA clinical data at DDW2026 event
Phathom unveils VOQUEZNA data

Phathom Pharmaceuticals will host a live product theater presentation on Monday, May 4 at 12:00 pm CDT during DDW2026, focusing on VOQUEZNA (vonoprazan).

The company will present updated data on the clinical efficacy and safety profile of VOQUEZNA, inviting healthcare professionals and stakeholders to learn more about this therapy. This session is positioned as part of the wider Digestive Disease Week program and reflects ongoing developments in treatments for gastric acid-related conditions.

Phathom has previously focused on outreach to healthcare professionals through industry events. Senior vice president Nancy Phelan spoke at a ThinkDHC webinar on point-of-care marketing and patient engagement. The company continues to leverage educational sessions to engage stakeholders in its therapeutic offerings.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.